Tribune Therapeutics
Operator of a preclinical biopharmaceutical company intended to treat fibrosis regardless of the cause, tissue, or diagnosis. The company specializes in developing novel medicines that target the fami...
Valuation
$0
Share Price
N/A
Total Raised
$39.7M
Last Round
N/A